Literature DB >> 26957960

Seropositivity and determinants of immunoglobulin-G (IgG) antibodies against Herpes simplex virus (HSV) types -1 and -2 in pregnant women in Port Harcourt, Nigeria.

Iheanyi Omezuruike Okonko1, Tochi Ifeoma Cookey1.   

Abstract

BACKGROUND: This study is the first documented prevalence of IgG antibody against HSV-1&-2 in Port Harcourt, Nigeria and thus provides baseline data for future in-depth studies on HSV infection in South-South, Nigeria.
OBJECTIVE: This study determined the seropositivity and determinants of serum IgG antibody against HSV-1 & HIV-2 among pregnant women attending BMSH, Port Harcourt, Rivers State, Nigeria.
METHODS: Serum samples from 180 pregnant women attending antenatal clinic at Braithwaite Memorial Specialist Hospital (BMSH) in Port Harcourt, Nigeria. Serum samples were analysed with commercial HSV type-1&-2 specific IgG Enzyme Linked Immunosorbent Assay (ELISA) kits. Chi-square analysis was used to determine the association of infection with socio-demographic variables.
RESULTS: Of the 180 pregnant women, 179 (99.4%) were seropositive and 1(0.6%) was seronegative for HSV 1&2 IgG antibody. No statistical association existed between the prevalence of HSV-1&-2 IgG antibodies and the socio-demographic variables studied (p>0.05) except for marital status which was significantly associated (p<0.05).
CONCLUSION: Our data shows that HSV-1 & 2 seropositivity among pregnant women in Port Harcourt is high; thus serological screening for HSV-1&-2 might be advisable for antenatal attendees.

Entities:  

Keywords:  BMSH; ELISA; HSV-1; HSV-2; IgG; determinants; seropositivity

Mesh:

Substances:

Year:  2015        PMID: 26957960      PMCID: PMC4765438          DOI: 10.4314/ahs.v15i3.6

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  24 in total

1.  Genital herpes and public health: addressing a global problem.

Authors:  L Corey; H H Handsfield
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

2.  TORCH agents in pregnant Saudi women.

Authors:  Hani O Ghazi; Abdulwahab M Telmesani; Mahomed F Mahomed
Journal:  Med Princ Pract       Date:  2002 Oct-Dec       Impact factor: 1.927

3.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

4.  Seroprevalence of HSV-1 and HSV-2 infection in the general French population.

Authors:  J E Malkin; P Morand; D Malvy; T D Ly; B Chanzy; C de Labareyre; A El Hasnaoui; S Hercberg
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

5.  The burden and risk factors of Sexually Transmitted Infections and Reproductive Tract Infections among pregnant women in Zimbabwe.

Authors:  Nyaradzai E Kurewa; Munyaradzi P Mapingure; Marshal W Munjoma; Mike Z Chirenje; Simbarashe Rusakaniko; Babill Stray-Pedersen
Journal:  BMC Infect Dis       Date:  2010-05-21       Impact factor: 3.090

6.  The interaction between herpes simplex virus and human immunodeficiency virus.

Authors:  Connie L Celum
Journal:  Herpes       Date:  2004-04

Review 7.  The importance of diagnosing genital herpes.

Authors:  M Cusini; M Ghislanzoni
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

Review 8.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review.

Authors:  Jennifer S Smith; N Jamie Robinson
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

9.  An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection.

Authors:  Katharine J Looker; Geoffrey P Garnett; George P Schmid
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

10.  Seroepidemiology of herpes simplex virus type 1 and 2 in northern iran.

Authors:  S Rezaei-Chaparpordi; M Assmar; N Amirmozafari; L Modiri; A Massiha; S Shokri-Fashtali; Z Gholizadeh; S Akbari
Journal:  Iran J Public Health       Date:  2012-08-31       Impact factor: 1.429

View more
  4 in total

1.  Seroprevalence of herpes simplex virus types 1 and 2 in Nigeria: a systematic review and meta-analyses.

Authors:  Eleazar E Reward; Sophia O Muo; Ibuchukwu N A Orabueze; Anthony C Ike
Journal:  Pathog Glob Health       Date:  2019-10-24       Impact factor: 2.894

Review 2.  Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice.

Authors:  Changchao Huan; Yao Xu; Wei Zhang; Tingting Guo; Haochun Pan; Song Gao
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 3.  Immune Response to Herpes Simplex Virus Infection and Vaccine Development.

Authors:  Anthony C Ike; Chisom J Onu; Chukwuebuka M Ononugbo; Eleazar E Reward; Sophia O Muo
Journal:  Vaccines (Basel)       Date:  2020-06-12

4.  The Effect of HSV-1 Seropositivity on the Course of Pregnancy, Childbirth and the Condition of Newborns.

Authors:  Irina Anatolyevna Andrievskaya; Irina Valentinovna Zhukovets; Inna Victorovna Dovzhikova; Nataliya Alexandrovna Ishutina; Ksenia Konstantinovna Petrova
Journal:  Microorganisms       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.